Trials / Sponsors / Atox Bio Ltd
Atox Bio Ltd
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury Acute Kidney Injury, Peritonitis, Necrotizing Soft Tissue Infection | Phase 3 | 2018-05-24 |
| Completed | Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infecti Necrotizing Soft Tissue Infections, Necrotizing Fasciitis, Fournier's Gangrene | Phase 3 | 2015-12-01 |
| Completed | Evaluation of Safety, PK and Immunomodulatory Effects of AB103 in Necrotizing Soft Tissue Infections Patients Necrotizing Soft Tissue Infections | Phase 2 | 2011-12-01 |
| Completed | AB103 Peptide Antagonist in Healthy Volunteers Healthy Volunteer Safety Study | Phase 1 | 2010-09-01 |